Dr. Korman's clinical interest is in the diagnosis and management of patients with scleroderma and other related autoimmune connective tissue diseases. He works to provide interdisciplinary care for patients including addressing problems with skin (fibrosis and thickening), blood vessels (Raynaud's phenomenon), gastrointestinal issues (acid reflux, GI motility problems), lung disease (interstitial lung disease, pulmonary hypertension), heart, and kidney problems. He is interested in providing individualized care and is well versed in cutting-edge immunotherapeutics as well symptom-relieving modalities.
Dr. Korman's research program focuses on understanding the cells and processes which cause scarring (fibrosis) in scleroderma. He uses both experimental models of disease and patient samples to better understand the relationship between adipose (fat) cells, blood vessels and scar-forming cells (fibroblasts). The ultimate goal of this work is to better understand why patients have different disease manifestations and to provide personalized treatment approaches.
Dr Benjamin Korman, M.D. is a rheumatologist and physician-scientist with a clinical and research interest in scleroderma (systemic sclerosis, SSc). Dr Korman did his undergraduate and medical training at The Ohio State University, followed by research time at the National Institutes for Health, and internal medicine residency and rheumatology fellowship training at Northwestern University in Chicago, IL. He spent two years on the faculty at Northwestern before coming to the University of Rochester where he now serves as an Assistant Professor in the Department of Medicine, Division of Allergy, Immunology, and Rheumatology.
Marangoni RG, Korman BD, Parra ER, Velosa APP, Barbeiro HV, Martins V, Dos Santos ABG, Soriano F, Teodoro WR, Silva PL, Tourtellotte W, Capelozzi VL, Varga J, Yoshinari NH. "Pathological pulmonary vascular remodeling is induced by type V collagen in a model of scleroderma." Pathology, research and practice.. 2021 Feb 19; 220:153382. Epub 2021 Feb 19.
De Pieri, A.; Korman, B.; Jüngel, A.; Wuertz-Kozak, K. "Engineering Advanced In Vitro Models of Systemic Sclerosis for Drug Discovery and Development." Advanced Biosystems. 2021; .
Shi B, Wang W, Korman B, Kai L, Wang Q, Wei J, Bale S, Marangoni RG, Bhattacharyya S, Miller S, Xu D, Akbarpour M, Cheresh P, Proccissi D, Gursel D, Espindola-Netto JM, Chini CCS, de Oliveira GC, Gudjonsson JE, Chini EN, Varga J. "Targeting CD38-dependent NAD metabolism to mitigate multiple organ fibrosis." iScience.. 2021 Jan 22; 24(1):101902. Epub 2020 Dec 07.
VIEW ALL PUBLICATIONS